Analyst Ratings for Trevi Therapeutics (TRVI)
TRVI Rating Summary
TRVI Price Target Summary
- Highest: $12.00 (Oppenheimer)
- Lowest: $10.00 (Needham & Company)
- Average: $10.67
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$10.67 (+184.4%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$10.67 (+184.4%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/25/2022 | Oppenheimer » Updated 6/30/2022 |
Leland Gershall | New Coverage | Outperform (N/A) |
12.00 (10.00) |
2.25 (3.75) |
66.67% | Details |
| 3/29/2022 | Aegis Capital | Nathan Weinstein | New Coverage | Buy (N/A) |
10.00 (N/A) |
2.16 (3.75) |
73.61% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
